Close Menu
Daily Guardian
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
What's On

ARO Network Raises $5M in Strategic Round to Build “The Agentic Edge”

March 29, 2026

Toronto Raptors go on historic 31-0 run

March 29, 2026

Crypto Poker No Deposit Bonus 2026: BC Poker Offers $5 Free Bonus on Sign-Up with App Download, Real Money Tables & Instant Crypto Payouts

March 29, 2026

Techbob Academy Launches Tech Elite Incubation Program to Standardize AI and STEAM Education Pathways

March 29, 2026

Jacob Wheeler Earns 11th Bass Pro Tour Win at Suzuki Marine Stage 4 Presented by Plano

March 29, 2026
Facebook X (Twitter) Instagram
Finance Pro
Facebook X (Twitter) Instagram
Daily Guardian
Subscribe
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
Daily Guardian
Home » Longevity Supplement Primeadine® GF Named 2026 NEXTY Award Finalist by New Hope Network
Press Release

Longevity Supplement Primeadine® GF Named 2026 NEXTY Award Finalist by New Hope Network

By News RoomFebruary 26, 20262 Mins Read
Longevity Supplement Primeadine® GF Named 2026 NEXTY Award Finalist by New Hope Network
Share
Facebook Twitter LinkedIn Pinterest Email

SHERIDAN, Wyo., Feb. 26, 2026 (GLOBE NEWSWIRE) — Oxford Healthspan is excited to announce that Primeadine® GF, its gluten-free, whole-food spermidine supplement, has been named a finalist for the 2026 NEXTY Awards.

Nearly 1,000 products were nominated for the 2026 NEXTY Awards, and after rigorous evaluation by an expert panel, 164 finalists across 37 categories were selected.

Primeadine® GF is one of six finalists in the Supplements for the Body category.

Unlike synthetic alternatives, Primeadine® GF delivers spermidine sourced from whole-food ingredients and formulated to support the body’s natural cellular renewal process known as autophagy. The gluten-free formula features a blend of ingredients all sourced from Okinawa, Japan: a unique strain of chlorella that is naturally high in spermidine, along with nobiletin from “Shikuwasa” citrus lime peel and turmeric, to complement spermidine’s role in supporting cellular health, metabolic resilience, and healthy aging.

“To be named a NEXTY finalist among so many brands in the U.S. natural products market is truly an honor,” said Leslie Kenny, Founder and CEO of Oxford Healthspan. “With nearly 1,000 products submitted and only 164 finalists, being recognized in that field carries real weight. For a company rooted in Japanese longevity science and based in Oxford to be acknowledged at this level in the U.S. affirms that clean, food-derived innovation and rigorous science truly matter in today’s wellness market.”

Oxford Healthspan is the only non-Japanese member of the Japan Autophagy Consortium, which has established a new certification program for supplements that claim to activate autophagy. The Consortium’s senior adviser is 2016 Nobel Laureate Professor Yoshinori Ohsumi, recognized for his discoveries in autophagy.

All Primeadine® products are third-party tested for purity and potency, ISO 22000-certified, and developed in collaboration with leading longevity researchers in Japan and the UK.

Winners of the 2026 NEXTY Awards will be announced during Natural Products Expo West in Anaheim, California.

For more information about Primeadine® GF, visit oxfordhealthspan.com.

About Oxford Healthspan
Oxford Healthspan is a women-led, science-backed longevity supplement company dedicated to helping people age on their own terms by delivering premium, whole-food longevity supplements grounded in rigorous global research and modern longevity science. With a mission to revolutionize healthy aging, Oxford Healthspan sources only the highest-quality ingredients from Japan to ensure purity, potency, and safety. Learn more at oxfordhealthspan.com and follow Oxford Healthspan on Instagram.

MEDIA CONTACT:
Lisa Lazarczyk, LAZ PR
Tel: 617.838.7327 or [email protected]

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/98110d96-07ff-4c10-93b7-efb4e1185fe2

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

Keep Reading

ARO Network Raises $5M in Strategic Round to Build “The Agentic Edge”

Crypto Poker No Deposit Bonus 2026: BC Poker Offers $5 Free Bonus on Sign-Up with App Download, Real Money Tables & Instant Crypto Payouts

Techbob Academy Launches Tech Elite Incubation Program to Standardize AI and STEAM Education Pathways

Jacob Wheeler Earns 11th Bass Pro Tour Win at Suzuki Marine Stage 4 Presented by Plano

NEXTRock, BCKD and SVCV Announce Proposed Convertible Senior Notes Offering and Bridge Fund

Bitcoin Everlight Opens Phase 3 as Stablecoin Adoption Expands Access to Blockchain Participation

ProDentim (URGENT REPORT 2026) Is ProDentim Legit? Ingredients, Benefits, Official Website, Complaints, and Customer Feedback

TitanPlay Focuses on Player Protection Through Culturally Aware Responsible Gambling Measures

TxFlow L1 Mainnet Launch Marks a New Phase for Multi-Application On-Chain Finance

Editors Picks

Toronto Raptors go on historic 31-0 run

March 29, 2026

Crypto Poker No Deposit Bonus 2026: BC Poker Offers $5 Free Bonus on Sign-Up with App Download, Real Money Tables & Instant Crypto Payouts

March 29, 2026

Techbob Academy Launches Tech Elite Incubation Program to Standardize AI and STEAM Education Pathways

March 29, 2026

Jacob Wheeler Earns 11th Bass Pro Tour Win at Suzuki Marine Stage 4 Presented by Plano

March 29, 2026

Latest News

Barnes leads Raptors in 139-87 romp over Magic

March 29, 2026

Angus, the C. difficile sniffing dog, celebrated as he retires after a decade

March 29, 2026

NEXTRock, BCKD and SVCV Announce Proposed Convertible Senior Notes Offering and Bridge Fund

March 29, 2026
Facebook X (Twitter) Pinterest TikTok Instagram
© 2026 Daily Guardian Canada. All Rights Reserved.
  • Privacy Policy
  • Terms
  • Advertise
  • Contact

Type above and press Enter to search. Press Esc to cancel.

Go to mobile version